Discontinuation report PROCYTOX
| Report ID | 265253 |
| Drug Identification Number | 02241797 |
| Brand name | PROCYTOX |
| Common or Proper name | Cyclophosphamide for Injection |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CYCLOPHOSPHAMIDE |
| Strength(s) | 200MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 200mg / 20mL vial (Prod. Code 2638B5039) |
| ATC code | L01AA |
| ATC description | ALKYLATINGAGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-12-31 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | If you have any questions regarding this communication, please do not hesitate to contact your BAXTER Pharmaceuticals Territory Manager or your BAXTER Customer Care team at 1.888.719.9955 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-08-14 | French | Compare |
| v1 | 2025-08-14 | English | Compare |
Showing 1 to 2 of 2